Evaluation of an Innovative Speech-enabled Translator in Emergency Settings
Sponsor
University Hospital, Geneva (Other)
Overall Status
Completed
CT.gov ID
NCT04788966
Collaborator
University of Geneva, Switzerland (Other)
42
1
13.7
3.1
Study Details
Study Description
Brief Summary
Survey-based satisfaction, performance and technical features evaluation of a speech-enabled fixed-phrase translation tool (BabelDR) in an emergency department.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
42 participants
Observational Model:
Ecologic or Community
Time Perspective:
Other
Official Title:
Evaluation of an Innovative Speech-enabled Translator in Emergency Settings
Actual Study Start Date
:
Nov 29, 2018
Actual Primary Completion Date
:
Jan 20, 2020
Actual Study Completion Date
:
Jan 20, 2020
Outcome Measures
Primary Outcome Measures
- Satisfaction evaluation through a 4-point scale survey [During the consultation]
Are patients' and doctors' satisfied with the use of BabelDr?
- Efficacy evaluation through a 2-point scale survey [During the consultation]
Can BabelDr be efficient tool in an emergency context: are doctors' able to reach a diagnostic with the tool?
- Technical features evaluation through a 4-point scale survey [During the consultation]
Are the technical features appreciated by the doctors'?
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- As per inclusion criteria, patients were required to have no understanding of French, thus making a diagnostic interview by the doctors impossible.
Exclusion Criteria:
- Exclusion criteria concerned patients who shared a common language with the doctor and/or were not able to read in their native language.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | University Hospitals of Geneva (HUG) | Geneva | Switzerland | 1205 |
Sponsors and Collaborators
- University Hospital, Geneva
- University of Geneva, Switzerland
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Antony Janakiram,
Research Assistant,
University Hospital, Geneva
ClinicalTrials.gov Identifier:
NCT04788966
Other Study ID Numbers:
- Réq 2017-00996
First Posted:
Mar 9, 2021
Last Update Posted:
Mar 9, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Antony Janakiram,
Research Assistant,
University Hospital, Geneva
Additional relevant MeSH terms: